Bliss Kelly sold $21K of TDOC
Bliss Kelly (President, U.S. Group Health) sold 2,500 shares of Teladoc Health, Inc. (TDOC) at $8.50 on 2026-06-29 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The newest fact is the specific sale size, price, and that it was executed under a pre-arranged 10b5-1 plan.
Market read
Traders may monitor for follow-on insider activity, but this particular sale is likely low-signal due to 10b5-1 pre-arrangement.
What to watch
The filing doesn’t disclose reasons for the sale; traders should avoid over-weighting insider selling when the plan is pre-arranged.
Background
The article is an SEC Form 4 insider transaction disclosure for Teladoc Health, Inc.
Ticker impact
Teladoc Health Form 4 shows President Bliss Kelly sold 2,500 shares at $8.50 on 2026-06-29 under a 10b5-1 plan.
Low likelihood of a sustained price move solely from this disclosure.
The filing is a Form 4 insider transaction with an explicitly pre-arranged 10b5-1 plan, which typically reduces interpretive weight versus discretionary selling.
Market effects
Minimal; this is company-specific insider activity with no sector-wide catalyst.
None indicated.
None indicated.
Counterpoint
Because it’s a 10b5-1 plan, the sale may be purely mechanical and not a bearish read-through.
Key entities
- issuerTeladoc Health, Inc.
Subject of the Form 4 insider transaction disclosure.
- insiderBliss Kelly
President, U.S. Group Health; reported an open-market sale of 2,500 shares.
